A stent is commonly used as a tubular structure left inside the lumen of a duct to relieve an obstruction. Commonly, stents are inserted into the lumen in a non-expanded form and are then expanded autonomously (or with the aid of a second device) in situ. A typical method of expansion occurs through the use of a catheter mounted angioplasty balloon, which is inflated within the stenosed vessel or body passageway, in order to shear and disrupt the obstructions associated with the wall components of the vessel and to obtain an enlarged lumen.
In the absence of a stent, restenosis may occur as a result of elastic recoil of the stenotic lesion. Although a number of stent designs have been reported, these designs have suffered from a number of limitations. These include restrictions on the dimension of the stent.
Other stents are described as longitudinally flexible but consist of a plurality of cylindrical elements connected together. This design has at least one important disadvantage, for example, according to this design, protruding edges occur when the stent is flexed around a curve raising the possibility of inadvertent retention of the stent on plaque deposited on arterial walls. This may cause the stent to form emboli or move out of position and further cause damage to the interior lining of healthy vessels.
Thus, stents are known in the art. Such stents may be expanded during or just after balloon angioplasty. As a general rule, the manufacture of a stent will need to compromise axial flexibility in order to permit expansion and provide overall structural integrity.
Prior stents have had a first end and a second end with an intermediate section between the two ends. The stent further has a longitudinal axis and comprises a plurality of longitudinally disposed bands, wherein each band defines a generally continuous wave along a line segment parallel to the longitudinal axis. A plurality of links maintains the bands in a tubular structure. In a further embodiment of the invention, each longitudinally disposed band of the stent is connected, at a plurality of periodic locations, by a short circumferential link to an adjacent band. The wave associated with each of the bands has approximately the same fundamental spatial frequency in the intermediate section, and the bands are so disposed that the waves associated with them are spatially aligned so as to be generally in phase with one another. The spatial aligned bands are connected, at a plurality of periodic locations, by a short circumferential link to an adjacent band.
In particular, at each one of a first group of common axial positions, there is a circumferential link between each of a first set of adjacent pairs of bands.
At each one of a second group of common axial positions, there is a circumferential link between each of a second set of adjacent rows of bands, wherein, along the longitudinal axis, a common axial position occurs alternately in the first group and in the second group, and the first and second sets are selected so that a given band is linked to a neighboring band at only one of the first and second groups of common axial positions.
Furthermore, this stent can be modified to provide for bifurcated access, whereas the stent itself is uniform throughout. If the manufacturer designs such a stent to have an large enough opening, then it is possible to place the stent such that a pair of stents can be placed one through the other. In this fashion, the stents are capable of being placed at a bifurcation, without any welding or any special attachments. An interlocking mechanism can be incorporated into the stent design to cause the stent to interlock at the desired position during assembly of the device.
Further, a metallic stent has been designed which contains a repeating closed loop feature. The stent is designed such that the closed loop does not change dimensions during expansion. The composite stent is created by filling the area enclosed by the loops with a material that enhances clinical performance of the stent. The material may be a ceramic or a polymer, and may be permanent or absorbable, porous or nonporous and may contain one or more of the following: a therapeutic agent, a radio-opaque dye, a radioactive material, or a material capable of releasing a therapeutic agent, such as rapamycin, cladribine, heparin, nitrous oxide or any other know drugs, either alone or in combination.
It has been seen, however, that it may be desirable to provide for stents that have both flexibility to navigate a tortuous lesion as well as increased column strength to maintain the rigidity necessary after emplacement into the lumen of the body. The preferred designs tend to provide the flexibility via undulating longitudinal connectors. The rigidity is generally provided via the mechanism of slotted tubular stents. It is perceived that there may be mechanisms capable of enhancing the characteristics of these types of stents. Such a stent would be both flexible in delivery and rigid upon emplacement.
Furthermore, it is desirable to be able to produce stents in which the cross-sectional profile of either the struts or the connecting members is tapered (or variable) in size. In addition, it may be desirable to modify stents to have non-rectangular cross-sections. In both these cases, different manufacturing methods may aid in the creation of such stents.
It is an object of the invention to provide a stent having has relatively little foreshortening.
It is an object of the invention to provide a stent having an enhanced degree of flexibility.
It is an object of the invention to provide such a stent while diminishing any compromise in the stent's structural rigidity upon expansion.
It is a further object of the invention to provide a novel method for manufacturing stents.
These and other objects of the invention are described in the following specification. As described herein, a preferred embodiment of a stent provides for a device that contains a flexible section and a folded strut section. The folded strut section opens (like a flower) upon expansion. This folded strut section provides both structural rigidity and reduction in foreshortening of the stent mechanism. The flexible section provides flexibility for delivery of the stent mechanism.
In a second embodiment of the device, there is a columnar section and a flexible section. The columnar section provides for a device that lengthens in the longitudinal direction upon expansion. The flexible section provides for a section that shortens somewhat in the longitudinal direction upon expansion. As a result, there is no shortening or lengthening of the stent during expansion. The flexible section columns are angled, one with respect to the other, and also with respect to the longitudinal axis of the stent, in order to provide flexibility during delivery. This arrangement also to also provide additional resistance to the balloon to prevent “dogboning” of the stent on the balloon during delivery and slippage of the balloon along the stent. These relatively flexible sections are oppositely phased with respect to one another in order to negate any torsion along their length. These flexible sections can further be crimped onto the balloon catheter with a generally smaller profile than prior stent, so that the retention of the stent on the balloon is increased.
In yet another embodiment of the stent of the present invention, the flexible connector can take on an undulating shape (like an “N”), but such that the longitudinal axis of the connector is not parallel with the longitudinal axis of the stent. In this fashion, the flexibility is controlled in a pre-selected axis, which is not the longitudinal axis of the stent. Such an arrangement may be desired, for instance, when one chooses to place a stent in a particularly configured vasculature that has been predetermined by known means, such as intravascular ultrasound (“IVUS.”)
In still a further embodiment of the present invention, there are provided “living hinge” connectors, which connect the generally flexible connectors to the stronger radial strut members. These living hinges accomplish a number of the same characteristics found in the prior embodiments disclosed herein. First, because the living hinges tend to expand upon inflation, foreshortening of the length of the stent is further reduced. Second, there is a combined radial strength provided at the intersection between the living hinges and the radial strut members. This creates a small “hoop,” which is further resistant to kinking or collapse in situ. Third, as a corollary to the second attribute described above, the living hinge connectors provide for reduced strain along an equivalent length of stent.
In yet another preferred embodiment of the stent of the present invention, the connection point between the radial members and the connector members is moved to a position along the length of a radial strut. Typically, the connection may be placed at a position somewhere midway along the length of the strut. By moving the connection point of the flex connectors closer to the midpoint of the radial ring one can address foreshortening in an controlled fashion. In fact, balloon interaction aside, the connector does not have to stretch to compensate for foreshortening. When the flex connectors are connected at the midpoint of the radial ring, the distance/length through the middle portion of the stent between radial rings will remain unchanged. This is because the midpoint stays relativiely in the same position while the radial arcs of each strut move closer to the midpoint from both sides. By moving the location of the flex connector attachment beyond the mid-point of a strut, to the opposing side, one can actually capitilize on the strut moving closer to the midpoint and thus lengthen the stent upon expansion.
In addition, in the present embodiment described, adjacent radially rings start out of phase in the unexpanded state. Due to the diagonal oreintation of the connection points of the flexible connectors, upon expansion the radial rings tend to align themselves (“in” phase.) This results in more uniform cell space and thus improved scaffolding of the vessel. Further, there is described a “wavy” strut configuration, thereby facilitating both a reduced crimp profile for attaching the flexible connectors at or near a strut mid-point and reduced strain upon expansion, due to the strut itself contributing to a portion of the expansion.
Finally, a new method is disclosed for making stents. In this method there is novel photochemical machining of a cylindrical tube. The method consists of performing a standard photochemical machining process of cutting, cleaning and coating the tube with a photoresist. However, unlike former methods, the photoresist image is developed on the surface of the cylindrical metallic tube, which results in a controlled variable etching rate at selected sites on the cylindrical metallic tube during the etching process. The photoresist image consists of a series of circular regions of photoresist of varying diameters configured at varying distances along the stent. As the diameter of the circular photoresist pattern decreases and the distance between the circular photoresist patterns along the stent increases, the etch rate of the device increases. The photoresist pattern variation results in a variation in the metal removed during the etching process.
This process can be used to locally change the geometry of the cylindrical metallic tube. An advantage seen by this process is the ability to manufacture a tapered strut along the stent. Further, struts of cylindrical or other non-rectangular cross-section can be manufactured. In addition, surface contours can be placed on the stent, for instance, to allow for a reservoir to be placed in the stent to deliver drugs.
These and further objects of the invention will be seen from the following drawings and Detailed Description of the Invention.
As can be seen in
Each of the folded struts 25 takes on a generally irregular pattern. On the other hand, each of the flexible sections 35 takes on a generally undulating pattern. The folded strut sections 20 wrap circumferentially around the cylindrical shape of the stent 10. Each flexible section 30 also connects to a folded strut section 20 around the circumference of the stent. It will be noticed that each adjacent flexible section 30 is positioned 180° out of phase with each other.
The longitudinal lengths of the folded struts 20 are short enough to give a smooth profile when the stent is bent. The folded strut 20 allows for a large diametrical expansion range upon expansion. So, upon expansion, the folded struts 20 expand circumferentially and become hoop-like so that maximum radial strength is achieved. The flexible members 30 placed between the folded struts improve the stent deliverability in the unexpanded dimension of the stent 10. These flexible members are longitudinally compliant so that foreshortening is minimized upon expansion.
In use, therefore, the stent 10 of the present invention is placed on a balloon catheter and is snaked through the vasculature to be placed into a lesion site in an artery, typically a coronary artery. Because the flexible sections 30 are so substantially flexible, they are able to navigate tortuous lesions with relative ease. Once in place, the balloon catheter is expanded by conventional means. Upon expansion, the struts 25 in the folded strut sections 20 expand to obtain a hoop-like shape. In addition, these members expand longitudinally, so that any reduction in foreshortening is negated. Of course, upon expansion, the flexible members 35 straighten so that there is further strength achieved by the stent in the straightened and rigid positions.
A variation of the present invention can be seen in the stent 50 of
The members that reduce foreshortening are angled members 130 which are seen to be 180° out of phase with one another. The connection between the flexible members is made at the end of a particular relatively non-flexible member and at the distal end of a particular angled canted member 130. Now, when the columns comprised of relatively rigid members 115 expand, the length of these members 130 shorten. But, the longitudinal lengths of the canted members 130 are placed at an angle compared to the longitudinal axis of the stent 50. So, upon expansion, these canted members 130 actually lengthen with respect to the longitudinal axis of the stent 50. The net result is that no foreshortening occurs upon expansion of stent 50.
The canted members 130 are angled in order to both: increase flexibility; and to provide additional resistance on the balloon surface. This arrangement helps prevent what is known as “dogboning” or exposure of leading edge of any of the strut members 75 contained at either end of the stent 50. In addition, this configuration also prevents slippage of the stent along the balloon surface. The canted members 130 are canted in opposite phase (i.e., with a phase change of 180°) to one another, in order to negate any torsional effects on the struts 75,85 along the length of the stent. These particular members can be crimped to a lower profile than the more rigid members, in order to ensure increased retention of the stent on the surface of a balloon catheter. Further the configuration described herein has a uniquely folded configuration reducing any risk of “flaring” of the edges of struts 75, 85 during traversal of the lumen.
It is to be noticed that the longitudinal position (the “order”) of the columns can be changed if one desires a smaller initial profile. That is, if one desires that the profile be smaller, it is possible to remove the more rigid sections 120 (or a portion thereof,) and replace them with the generally canted sections 130.
It is also to be noticed that the wave amplitudes of the struts in a particular column are not kept constant. The wave amplitudes, defined herein as “W,” can be lengthened where permitted by the geometry. For instance, notice the space S created between one set of strut members A and a second set of strut members B. This particular configuration allows an increased expansion range around the unexpanded circumference of the stent, while maintaining an appropriate expansion area associated with the metallic struts placed around of the circumference of the stent. Such optimization of the strut surface area is important to ensure adequate coverage of the lesion upon expansion of the stent.
The stent 50 of this particular embodiment is expanded in much the same way as the stent 10 of
As can be seen in
In the stent 200, the relatively rigid sections R contain unequal struts 210, 220 of lengths a, b, as can best be seen in
As can be seen from
As can be seen from the figures, in some radial positions, the struts 210 are made longer. In other radial positions, the struts 220 are made shorter. However, the shorter struts 220 are of a constant length b in the longitudinal dimension, and in the fashion in which they connect to the relatively flexible connectors 250. Also, as described above, the relatively more rigid sections R maintain the relatively more flexible sections F at a generally constant longitudinal length due to the friction maintained by the relatively more rigid sections R on a balloon portion of an angioplasty type balloon catheter. Accordingly, upon expansion, the constant length b, in conjunction with the generally constant length of the relatively flexible connector 250, causes the stent 200 to maintain a relatively constant longitudinal dimension L in any diameter to which it is expanded. As can be appreciated, the maintenance of a constant length is desirable from the perspective of secure, repeatable placement of the stent within the vasculature.
Continuing to describe the stent 200 of
As can be best seen in
Known conventional means, such as angioplasty balloons, or the balloon on a stent delivery system expands the stent 300 of the present invention. Upon expansion, there are provided a number of benefits by the stent 300 of the present invention. First, as explained above, there is reduced foreshortening of the stent 300, since the outer radial arc 332 in fact does not foreshorten. Since it lengthens slightly, the overall length of the stent 300 is maintained to its general nominal length. There is also provided increased radial strength since the radial arcs 332, 334 at their connection between the flexible and radial struts 320, 310, (both inner and outer radial arcs 334, 332) combine to give superior strength in the arcs' section; the radial strut 310 provides for optimal strength in the radial direction since it is parallel to the loading direction of the stent 300, thereby creating a “hoop” a circumference C of the stent. Also, because the radial arcs are able to accept greater forces, there is reduced strain for the equivalent strength designed for a stents. In all, the stent 300 of this embodiment provides for at least equivalent radial strength, less foreshortening and reduced strain when compared to current stents.
As can be seen from
Due to this overall ability to maintain the length of stent 400, the radial struts 410 provide for radial strength only, and do not contribute in one way or another to any foreshortening of the stent. Also, the radial struts 410 are formed from a generally “wavy” pattern. This wavy pattern is useful in helping to reduce the crimp profile of the stent 400 on the balloon. This results from the relative smooth attachment of the radial struts 410 to the flexible connectors 420. Further, having such an arrangement reduces the strain placed on the struts 420 upon expansion. This reduced strain is achieved due to the location of the connection of the struts 420 to the struts 410. Because there is relatively little movement of the struts 420 in the longitudinal direction, there is relatively little strain placed on these struts during expansion. The radial arcs 415 of struts 410 can be ideally placed in a “shifted” configuration so that the stent is easier to crimp on a balloon.
Further, this can be seen from
From
It is to be understood that various modifications to the stent 400 of
These stents can be manufactured by know conventional means, such as laser etching, electrical discharge machining (EDM), photochemical etching, etc. However, there is also disclosed in the invention herein a novel method of performing photochemical resistance etching of the tube from which the stent is to be made. This novel method allows one to produce a stent with variable geometry in the three dimensions of the strut, that is, along its length, across the circumferential dimension, and along its depth (or radial dimension.) This method starts with a standard photochemical machining process.
The new process consists of cutting the stent using photochemical etching, cleaning it, and then coating it with a photoresist. The photoresist coating is applied in circular shapes 290, as can be appreciated from
As previously stated, the novel photoresist image can be seen in
This photoresist pattern 310 variation results in a variation in the metal of the stent removed during the etching process. This process can be used to locally change the geometry of the metallic tube.
In this fashion, one can envision making a stent of variable circumferential width, radial depth or longitudinal length. As such, one can impart varying flexibilities along the stent longitude, as well as varying strengths so that a stent can be configured for emplacement at various locations within the body.
This application is a continuation of application Ser. No. 09/797,642, filed Mar. 2, 2001, now Pat. No. 6,955,686, which is the non-provisional of application Ser. No. 60/272,696, filed Mar. 1, 2001, now abandoned. The complete disclosures of the aforementioned related U.S. patent applications are hereby incorporated herein by reference for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
1205743 | Didcott | Sep 1916 | A |
3657744 | Ersek | Apr 1972 | A |
4441216 | Ionescu et al. | Apr 1984 | A |
4503569 | Dotter | Mar 1985 | A |
4514154 | Mazzagatti | Apr 1985 | A |
4522757 | Hsu et al. | Jun 1985 | A |
4553545 | Maass et al. | Nov 1985 | A |
4580568 | Gianturco | Apr 1986 | A |
4733665 | Palmaz | Mar 1988 | A |
4776337 | Palmaz | Oct 1988 | A |
4800882 | Gianturco | Jan 1989 | A |
4856516 | Hillstead | Aug 1989 | A |
4886062 | Wiktor | Dec 1989 | A |
4907336 | Gianturco | Mar 1990 | A |
4969458 | Wiktor | Nov 1990 | A |
4990131 | Dardik et al. | Feb 1991 | A |
4990155 | Wilkoff | Feb 1991 | A |
4994071 | MacGregor | Feb 1991 | A |
5015253 | MacGregor | May 1991 | A |
5035706 | Giantureo et al. | Jul 1991 | A |
5041126 | Gianturco | Aug 1991 | A |
5064435 | Porter | Nov 1991 | A |
5102417 | Palmaz | Apr 1992 | A |
5104404 | Wolff | Apr 1992 | A |
5116365 | Hillstead | May 1992 | A |
5122154 | Rhodes | Jun 1992 | A |
5131908 | Dardik et al. | Jul 1992 | A |
5133732 | Wiktor | Jul 1992 | A |
5135536 | Hillstead | Aug 1992 | A |
5163958 | Pinchuk | Nov 1992 | A |
5171262 | MacGregor | Dec 1992 | A |
5176660 | Truckai | Jan 1993 | A |
5178618 | Kandarpa | Jan 1993 | A |
5192307 | Wall | Mar 1993 | A |
5195984 | Schatz | Mar 1993 | A |
5217483 | Tower | Jun 1993 | A |
5222971 | Willard et al. | Jun 1993 | A |
5246445 | Yachia et al. | Sep 1993 | A |
5258021 | Duran | Nov 1993 | A |
5266073 | Wall | Nov 1993 | A |
5275622 | Lazarus et al. | Jan 1994 | A |
5282823 | Schwartz et al. | Feb 1994 | A |
5282824 | Gianturco | Feb 1994 | A |
5290305 | Inoue | Mar 1994 | A |
5292331 | Boneau | Mar 1994 | A |
5304200 | Spaulding | Apr 1994 | A |
5314444 | Gianturco | May 1994 | A |
5314472 | Fontaine | May 1994 | A |
5334301 | Heinke et al. | Aug 1994 | A |
5342387 | Summers | Aug 1994 | A |
5354257 | Roubin et al. | Oct 1994 | A |
5354308 | Simon et al. | Oct 1994 | A |
5366504 | Andersen et al. | Nov 1994 | A |
5370683 | Fontaine | Dec 1994 | A |
5370691 | Samson | Dec 1994 | A |
5375612 | Cottenceau et al. | Dec 1994 | A |
5376112 | Duran | Dec 1994 | A |
5382261 | Palmaz | Jan 1995 | A |
5387235 | Chuter | Feb 1995 | A |
5389106 | Tower | Feb 1995 | A |
5395390 | Simon et al. | Mar 1995 | A |
5397355 | Marin et al. | Mar 1995 | A |
5403341 | Solar | Apr 1995 | A |
5405377 | Cragg | Apr 1995 | A |
5411549 | Peters | May 1995 | A |
D359802 | Fontaine | Jun 1995 | S |
5421955 | Lau et al. | Jun 1995 | A |
5423885 | Williams | Jun 1995 | A |
5441515 | Khosravi et al. | Aug 1995 | A |
5441516 | Wang et al. | Aug 1995 | A |
5443477 | Marin et al. | Aug 1995 | A |
5443496 | Marin et al. | Aug 1995 | A |
5443498 | Schwartz et al. | Aug 1995 | A |
5443500 | Fontaine | Aug 1995 | A |
5449372 | Schmaltz et al. | Sep 1995 | A |
5449373 | Pinchasik et al. | Sep 1995 | A |
5449382 | Dayton | Sep 1995 | A |
5496365 | Sgro | Mar 1996 | A |
5527354 | Fontaine et al. | Jun 1996 | A |
5549662 | Fordenbacher | Aug 1996 | A |
5569295 | Lam | Oct 1996 | A |
5591197 | Orth et al. | Jan 1997 | A |
5632763 | Glastra | May 1997 | A |
5643312 | Fischell et al. | Jul 1997 | A |
5649952 | Lam | Jul 1997 | A |
5653747 | Dereume | Aug 1997 | A |
5669924 | Shaknovich | Sep 1997 | A |
5695516 | Fischell et al. | Dec 1997 | A |
5697971 | Fischell et al. | Dec 1997 | A |
5718713 | Frantzen | Feb 1998 | A |
5733303 | Israel et al. | Mar 1998 | A |
5735893 | Lau et al. | Apr 1998 | A |
5741327 | Frantzen | Apr 1998 | A |
5741429 | Donadio, III et al. | Apr 1998 | A |
5755734 | Richter et al. | May 1998 | A |
5755776 | Al-Saadon | May 1998 | A |
5755781 | Jayaraman | May 1998 | A |
5776161 | Globerman | Jul 1998 | A |
5776183 | Kanesaka et al. | Jul 1998 | A |
5800508 | Goicoechea et al. | Sep 1998 | A |
5807404 | Richter | Sep 1998 | A |
5810872 | Kanesaka et al. | Sep 1998 | A |
5815904 | Clubb et al. | Oct 1998 | A |
5827321 | Roubin et al. | Oct 1998 | A |
5836964 | Richter et al. | Nov 1998 | A |
5843120 | Israel et al. | Dec 1998 | A |
5855600 | Alt | Jan 1999 | A |
5855802 | Acciai et al. | Jan 1999 | A |
5861027 | Trapp | Jan 1999 | A |
5868781 | Killion | Feb 1999 | A |
5876449 | Starck et al. | Mar 1999 | A |
5902475 | Trozera et al. | May 1999 | A |
5911754 | Kanesaka et al. | Jun 1999 | A |
5913895 | Burpee et al. | Jun 1999 | A |
5922020 | Klein et al. | Jul 1999 | A |
5922021 | Jang | Jul 1999 | A |
5925061 | Ogi et al. | Jul 1999 | A |
5935162 | Dang | Aug 1999 | A |
5948016 | Jang | Sep 1999 | A |
5954743 | Jang | Sep 1999 | A |
5955499 | Choi et al. | Sep 1999 | A |
5972018 | Israel et al. | Oct 1999 | A |
6001123 | Lau | Dec 1999 | A |
6013854 | Moriuchi | Jan 2000 | A |
6017365 | Von Oepen | Jan 2000 | A |
6019789 | Dinh et al. | Feb 2000 | A |
6027526 | Limon et al. | Feb 2000 | A |
6027863 | Donadio, III | Feb 2000 | A |
6033433 | Ehr et al. | Mar 2000 | A |
6033435 | Penn et al. | Mar 2000 | A |
6059811 | Pinchasik et al. | May 2000 | A |
6066169 | McGuinness | May 2000 | A |
6068656 | Von Oepen | May 2000 | A |
6090127 | Globerman | Jul 2000 | A |
6113627 | Jang | Sep 2000 | A |
6117165 | Becker | Sep 2000 | A |
6123721 | Jang | Sep 2000 | A |
6129754 | Kanesaka et al. | Oct 2000 | A |
6171334 | Cox | Jan 2001 | B1 |
6174329 | Callol et al. | Jan 2001 | B1 |
6179867 | Cox | Jan 2001 | B1 |
6190403 | Fischell et al. | Feb 2001 | B1 |
6190405 | Culombo et al. | Feb 2001 | B1 |
6193747 | von Oepen | Feb 2001 | B1 |
6203569 | Wijay | Mar 2001 | B1 |
6217608 | Penn et al. | Apr 2001 | B1 |
6231598 | Berry et al. | May 2001 | B1 |
6253443 | Johnson | Jul 2001 | B1 |
6261319 | Kveen et al. | Jul 2001 | B1 |
6264688 | Herklotz et al. | Jul 2001 | B1 |
6287336 | Globerman et al. | Sep 2001 | B1 |
6293967 | Shanley | Sep 2001 | B1 |
6309414 | Rolando et al. | Oct 2001 | B1 |
6312459 | Huang et al. | Nov 2001 | B1 |
6325821 | Gaschino et al. | Dec 2001 | B1 |
6325825 | Kula et al. | Dec 2001 | B1 |
6340366 | Wijay | Jan 2002 | B2 |
6342067 | Mathis et al. | Jan 2002 | B1 |
6344055 | Shukov | Feb 2002 | B1 |
6423090 | Hancock | Jul 2002 | B1 |
6428570 | Globerman | Aug 2002 | B1 |
6451049 | Vallana et al. | Sep 2002 | B2 |
6540775 | Fischell et al. | Apr 2003 | B1 |
6773455 | Allen et al. | Aug 2004 | B2 |
6845572 | Haimerl et al. | Jan 2005 | B1 |
6955686 | Majercak et al. | Oct 2005 | B2 |
20010044653 | Brown et al. | Nov 2001 | A1 |
20020111669 | Paziena et al. | Aug 2002 | A1 |
20030065383 | Pinchasik et al. | Apr 2003 | A1 |
Number | Date | Country |
---|---|---|
2195783 | Feb 1996 | CA |
2333764 | Dec 1999 | CA |
2397373 | Sep 2000 | CA |
2280131 | Aug 2008 | CA |
3205942 | Sep 1983 | DE |
32 25 206 | Oct 1983 | DE |
297 01 758 | May 1997 | DE |
297 02 671 | May 1997 | DE |
297 08 689 | Aug 1997 | DE |
297 08 879 | Sep 1997 | DE |
297 16 476 | Feb 1998 | DE |
197 53 123 | Aug 1999 | DE |
0 540 290 | May 1993 | EP |
0 734 698 | Oct 1996 | EP |
0 800 801 | Oct 1997 | EP |
0 824 900 | Feb 1998 | EP |
0 830 853 | Mar 1998 | EP |
0 875 215 | Apr 1998 | EP |
0 887 051 | Dec 1998 | EP |
0 887 051 | Dec 1998 | EP |
884029 | Dec 1998 | EP |
890346 | Jan 1999 | EP |
0 938 878 | Sep 1999 | EP |
0 970 664 A2 3 | Jan 2000 | EP |
1 042 997 | Oct 2000 | EP |
1 074 227 | Feb 2001 | EP |
566807 | Feb 1924 | FR |
6-41745 | Jun 1994 | JP |
WO 9603092 | Feb 1996 | WO |
WO 9626689 | Sep 1996 | WO |
WO 9634580 | Nov 1996 | WO |
WO 9704721 | Feb 1997 | WO |
WO 9714375 | Apr 1997 | WO |
WO 9725000 | Jul 1997 | WO |
WO 9725937 | Jul 1997 | WO |
WO 9726840 | Jul 1997 | WO |
WO 9732543 | Sep 1997 | WO |
WO 9732544 | Sep 1997 | WO |
WO 9733534 | Sep 1997 | WO |
WO 9740780 | Nov 1997 | WO |
WO 9740783 | Nov 1997 | WO |
WO 9818405 | May 1998 | WO |
WO 9819628 | May 1998 | WO |
WO 9838946 | Sep 1998 | WO |
WO 9845506 | Oct 1998 | WO |
WO 9962430 | Oct 1998 | WO |
WO 9848733 | Nov 1998 | WO |
WO 9915108 | Apr 1999 | WO |
WO 9917680 | Apr 1999 | WO |
WO 9949928 | Oct 1999 | WO |
WO 0002502 | Jan 2000 | WO |
WO 0062710 | Oct 2000 | WO |
WO 0068710 | Oct 2000 | WO |
WO 0066034 | Nov 2000 | WO |
WO 0100112 | Jan 2001 | WO |
WO 0100112 | Jan 2001 | WO |
WO 0141675 | Jun 2001 | WO |
Number | Date | Country | |
---|---|---|---|
20050165474 A1 | Jul 2005 | US |
Number | Date | Country | |
---|---|---|---|
60272696 | Mar 2001 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09797642 | Mar 2001 | US |
Child | 11084834 | US |